Brief: Glycomimetics Inc Received Notice From Nasdaq Stock Market That Co Is Not In Compliance With Nasdaq's Listing Rule 5450(A)(1)
03/06/2022 21:03
June 3 (Reuters) - GlycoMimetics Inc GLYC.O :
* GLYCOMIMETICS INC - ON MAY 31, RECEIVED A NOTICE FROM
NASDAQ
STOCK MARKET THAT CO IS NOT IN COMPLIANCE WITH NASDAQ'S LISTING
RULE 5450(A)(1)
Further company coverage: GLYC.O
Recent news on Crescent Biopharma
See all newsBrief: Crescent Biopharma - Potential To Initiate First CR-001 Phase 3 Study In Early 2028
Brief: Crescent Biopharma Announces FDA Clearance Of Ind Application For CR-002, A Pd-L1-Targeted Topoisomerase Inhibitor Adc, For The Treatment Of Solid Tumors
Crescent Biopharma posts smaller-than-expected Q2 net loss
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Crescent Biopharma slips on $125 mln share offering